Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02170181 · ClinicalTrials.gov registry record
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 149
- Enrollment target
NCT02170181 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 149 participants.
The verdict
NCT02170181 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 149 participants
- Enrollment target
Study Summary
This prospective protocol will enroll patients with pathologically confirmed solid malignancies who receive stereotactic body radiation therapy (SBRT) for oligometastases, for consolidation after systemic therapy, prior to systemic therapy for the purposes of debulking, or in the re-irradiation setting. Increasing use of SBRT off of clinical trials in patients with malignancies of all histologies is being utilized in these settings. However, individualized outcomes and characteristics of treatments are not prospectively followed and not well documented. By instituting a registry of patients receiving SBRT in these settings it will be possible to determine trends in patterns of care and outcomes for refinement and justification of this treatment.
Interventions
- RADIATION SBRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2014-05-28 |
| Est. Completion | 2025-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02170181
The ClinicalTrials.gov registry entry for NCT02170181 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SBRT is the first listed.
NCT02170181 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02170181 about?
NCT02170181 is a clinical study titled "Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation". This prospective protocol will enroll patients with pathologically confirmed solid malignancies who receive stereotactic body radiation therapy (SBRT) for oligometastases, for consolidation after systemic therapy, prior to systemic therapy for the purposes of debulking, or in the re-irradiation sett...
What is the current status of trial NCT02170181?
This trial is currently completed. The enrollment target is 149 participants. The study started on 2014-05-28. Estimated completion is 2025-08.
What interventions are being tested in trial NCT02170181?
The interventions under investigation include: SBRT (RADIATION).
Who is sponsoring clinical trial NCT02170181?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.